Health CanadaGeneral Alert
Health Canada directs Hoffmann-La Roche to remove use of Avastin (bevacizumab) for the treatment of metastatic breast cancer from the product label
Published: November 28, 2011Recall ID: 22981Category: generalCountry: Canada
Safety AlertHealth CanadaCanada
CanadaHealth Canada directs Hoffmann-La Roche to remove use of Avastin (bevacizumab) for the treatment of metastatic breast cancer from the product label
Recalling Firm: Communications and Public Affairs Branch
Product Description & Identification
Health Canada directs Hoffmann-La Roche to remove use of Avastin (bevacizumab) for the treatment of metastatic breast cancer from the product label
Additional Source Details
| Field | Value |
|---|---|
| N I D | 22981 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/health-canada-directs-hoffmann-roche-remove-use-avastin-bevacizumab-treatment |
| Title | Health Canada directs Hoffmann-La Roche to remove use of Avastin (bevacizumab) for the treatment of metastatic breast cancer from the product label |
| Archived | 1 |
| Category | Drugs |
| Last updated | 2011-11-28 |
| Organization | Communications and Public Affairs Branch |
Check Other Products In Your Household
Free Safety ToolsSafety recalls are issued daily across foods, medications, vehicles, and electronics. Use our instant tools to check your home for active safety warnings:
Overview
- Recalling FirmCommunications and Public Affairs Branch
Recall Hazard Severity
Official Agency AlertCaution (Class III)
📢 Share Warning
Alert family and friends to keep them safe. Copy this quick alert message:
🚨 SAFETY ALERT: Communications and Public Affairs Branch - Health Canada directs Hoffmann-La Roche to remove use of Avastin (bevacizumab) for the treatment of metastatic breast cancer from the product label Check if your household is affected: https://therecallfile.com/recalls/health-canada-directs-hoffmann-la-roche-to-remove-use-of-avastin-bevac/CANADA-22981
Join Alertlist
Get instant email updates whenever critical safety recalls like this are published.
Featured on Product Hunt
Help support our public safety mission and check out our community launch.
Support The Recall File
Help keep official recall alerts free, accessible, and fast for everyone.
Spread the WordHealth Canada directs Hoffmann-La Roche to remove use of Avastin (bevacizumab) for the treatment of metastatic breast cancer from the product label
Related Recalls
Safety AlertHealth Canada
Health CanadaTransport Canada Recall - 2018088 -
TC
Health CanadaGeneral Alert
Transport Canada Recall - 2018088 -
Tires
—TC
Safety AlertHealth Canada
Health CanadaTransport Canada Recall - 2018288 -
TC
Health CanadaGeneral Alert
Transport Canada Recall - 2018288 -
Airbag
—TC
Safety AlertHealth Canada
Health CanadaTransport Canada Recall - 2018409 -
TC
Health CanadaGeneral Alert
Transport Canada Recall - 2018409 -
Airbag
—TC